U.S. Physical Therapy, Inc. Plans Quarterly Dividend of $0.44 (NYSE:USPH)

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) announced a quarterly dividend on Tuesday, May 7th, Zacks reports. Stockholders of record on Thursday, May 23rd will be given a dividend of 0.44 per share on Friday, June 14th. This represents a $1.76 annualized dividend and a dividend yield of 1.67%. The ex-dividend date of this dividend is Wednesday, May 22nd.

U.S. Physical Therapy has raised its dividend payment by an average of 75.2% annually over the last three years and has increased its dividend every year for the last 5 years. U.S. Physical Therapy has a payout ratio of 57.0% meaning its dividend is sufficiently covered by earnings. Equities analysts expect U.S. Physical Therapy to earn $3.06 per share next year, which means the company should continue to be able to cover its $1.76 annual dividend with an expected future payout ratio of 57.5%.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH traded up $1.16 during mid-day trading on Thursday, hitting $105.08. 60,976 shares of the stock were exchanged, compared to its average volume of 69,231. The company has a market cap of $1.58 billion, a P/E ratio of 77.76, a PEG ratio of 4.99 and a beta of 1.39. The stock's fifty day simple moving average is $105.34 and its two-hundred day simple moving average is $96.37. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.28 and a current ratio of 2.28. U.S. Physical Therapy has a twelve month low of $78.08 and a twelve month high of $124.11.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.58 by ($0.07). The firm had revenue of $155.70 million for the quarter, compared to analyst estimates of $153.30 million. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The business's quarterly revenue was up 4.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.59 EPS. As a group, analysts forecast that U.S. Physical Therapy will post 2.77 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

USPH has been the topic of several research analyst reports. JPMorgan Chase & Co. increased their price target on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the company an "overweight" rating in a research note on Wednesday, March 13th. StockNews.com raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Monday, March 18th. Finally, Barrington Research reissued an "outperform" rating and set a $122.00 price target on shares of U.S. Physical Therapy in a research note on Thursday. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, U.S. Physical Therapy currently has an average rating of "Moderate Buy" and a consensus price target of $125.67.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 1,800 shares of the firm's stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total value of $193,104.00. Following the transaction, the chief financial officer now directly owns 21,186 shares of the company's stock, valued at $2,272,834.08. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other U.S. Physical Therapy news, EVP Richard Binstein sold 2,000 shares of the business's stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $106.55, for a total value of $213,100.00. Following the completion of the transaction, the executive vice president now directly owns 15,006 shares of the company's stock, valued at $1,598,889.30. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Carey P. Hendrickson sold 1,800 shares of the stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $107.28, for a total value of $193,104.00. Following the completion of the sale, the chief financial officer now owns 21,186 shares of the company's stock, valued at $2,272,834.08. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 10,829 shares of company stock valued at $1,141,535. 1.70% of the stock is currently owned by insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.